AIRE gene mutation
The AIRE gene is located on locus 21q22.3 and contains 14 exons, encoding a 545-amino acid protein called the autoimmune regulator. This protein plays a critical role in immune defense by regulating autoantigen expression and enabling negative selection of autoreactive T lymphocytes in thymus gland (thymic education). For proper health, our immune system should distinguish self-antigens from non-self ones and destroy invading foreigners (bacteria, viruses, etc.). If it fails due to genetic defects such as AIRE gene mutations, the immune network will attack and damage the body’s own tissues, resulting in autoimmunity.
Over 90 mutations in the AIRE gene have been determined in people with an autoimmune disease called Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) also known as autoimmune polyendocrine syndrome type I (APS-1). APECED is an inherited condition, usually recessively inherited and affects many organs and tissues. A major feature of this disorder is chronic mucocutaneous candidiasis (CMC), which is a tendency to develop infections of the skin, the nails, and the moist lining of body cavities (mucous membranes) caused by a type of fungus called Candida. Other common signs and symptoms of APECED involve dysfunction of the body's network of hormone-producing glands (the endocrine system), as well as other organs and tissues.
The clinical diagnosis of APECED requires the presence of at least two of the following 3 classical conditions: chronic mucocutaneous candidiasis, hypoparathyroidism, or Addison's disease. The best way to diagnose APECED is by DNA sequencing technology, which can detect mutations of the AIRE gene.
- As an aid in diagnosis of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy
- Prenatal carrier screening and identification of at-risk family members
- There are more than 90 mutations which will have a different impact on the protein function.
- The severity of disease will depend on the mutation and combination of mutations detected. Since this is a recessive genetic disorder, detection of heterozygous mutation will confirm carriers.
- Combination of heterozygous and homozygous will diagnose disease.
Negative for mutations analyzed
Whole blood (EDTA), Extracted DNA, Cultured cells: 2 T-25 flasks of Fibroblasts, Amniocytes, or Chorionic villus sampling.
Stability
- Cultured cells: 3 days in room temperature
Whole blood or extracted DNA:
- Ambient: 3 days
- Refrigerated: 7 days
- Int J Mol Sci. 2016 Jul 12;17(7). [PMID: 27420045]
- J Clin Aesthet Dermatol. 2012 Dec; 5(12): 18–22. [PMID: 23277800]
- Int J Endocrinol. 2012;2012:353250. [PMID: 23133448]
- Front Immunol. 2013 Oct 7;4:313. [PMID: 24109480]
- Chronic mucocutaneous candiadiasis. UpToDate May 26, 2015
- Nat Rev Immunol. 2016 Apr;16(4):247-58. [PMID: 26972725]